IP vs KYMR · P/E 43, $26.62B cap vs rev $47.1M
International Paper (IP) versus Kymera Therapeutics Inc (KYMR) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported KYMR revenue for 2024-12-31 was $47.1M. Net income was -$223.9M. Revenue was down 40.1% from 2023-12-31 to 2024-12-31. KYMR currently screens at market cap $7.39B.
IP currently screens at market cap $26.62B and trailing P/E 43.1. KYMR currently screens at market cap $7.39B.
Not investment advice. Open the IP and KYMR stock pages for the full models.
Not investment advice.